Robbins Farley’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.1K Hold
655
0.02% 84
2026
Q1
$55.8K Sell
655
-195
-23% -$17.4K 0.02% 79
2025
Q4
$67.2K Hold
850
0.03% 74
2025
Q3
$67.9K Sell
850
-120
-12% -$10.2K 0.03% 82
2025
Q2
$88.2K Hold
970
0.04% 70
2025
Q1
$90.9K Hold
970
0.05% 63
2024
Q4
$88.2K Hold
970
0.04% 64
2024
Q3
$101K Hold
970
0.05% 67
2024
Q2
$94.1K Hold
970
0.05% 67
2024
Q1
$87.3K Buy
+970
New +$82.2K 0.05% 68

Other funds holding CL

Robbins Farley's CL Position: Q2 2026 in Review

Robbins Farley held its Colgate-Palmolive (CL) position steady in Q2 2026 at 655 shares worth $60.1K. The position accounts for 0.02% of the portfolio, ranked #84.

Robbins Farley first reported a position in CL in Q1 2024 and has held it in 10 quarters since. The position peaked at $101K in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Robbins Farley held 655 shares of Colgate-Palmolive worth $60.1K as of Q2 2026.
  • Robbins Farley left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.02% of Robbins Farley's portfolio in Q2 2026, its #84 holding.
  • Robbins Farley first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • Robbins Farley's Colgate-Palmolive position peaked at $101K in Q3 2024.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Robbins Farley's 13F filing for Q2 2026, filed 23 Jul 2026.